Skip to main content

Articles

Page 50 of 55

  1. Authors: Giorgio Zanchin

    Citation: The Journal of Headache and Pain 2004 5:140

    Content type: HISTORY OF HEADACHE SECTION

    Published on:

  2. The following is the case of a 55-year-old woman showing palpebral ecchymoses ipsilateral to the symptomatic side during migraine episodes. The lesions are not associated with oedema or other vegetative manife...

    Authors: Donato Nozzolillo, Claudio Negro, Cecilia Nozzoli, Augusto de Rini, Vincenzo Marco and Bruno Passarella

    Citation: The Journal of Headache and Pain 2004 5:136

    Content type: BRIEF REPORT

    Published on:

  3. The objective was to assess the effect of botulinum toxin type-A (BTX-A) in treating chronic tension-type headache (CTTH). A single centre, open label, pilot study was carried out at the Headache and Pain Cent...

    Authors: Mauro Porta and Giorgio Maggioni

    Citation: The Journal of Headache and Pain 2004 5:135

    Content type: BRIEF REPORT

    Published on:

  4. The objective was to identify a subset of preferred triptans from among available agents. A criterion of dominance was applied to statistically significant differences which emerged from a recent meta-analysis...

    Authors: Douglas C. McCrory and Paul Williams

    Citation: The Journal of Headache and Pain 2004 5:134

    Content type: BRIEF REPORT

    Published on:

  5. Septoplasty is one of the most common nasal operations performed in otorhinolaryngological practice. At the end of the operation, most surgeons place nasal packings and remove them after 48–72 hours. The remov...

    Authors: Emine O. Tulunay, Faik C. Tulunay, Sinem E. Gulmez, Hakan Ergun and Alp Demireller

    Citation: The Journal of Headache and Pain 2004 5:133

    Content type: ORIGINAL

    Published on:

  6. The objectives were to compare patient preference for zolmitriptan nasal spray with their current acute therapies for migraine (by asking whether or not they wished to continue to use zolmitriptan nasal spray)...

    Authors: Carl G. H. Dahlöf, Mattias Linde and Erika Kerekes

    Citation: The Journal of Headache and Pain 2004 5:132

    Content type: ORIGINAL

    Published on:

  7. With the rapid advances in the treatment of migraine attacks in the last few years, a number of non-specific anti-migraine drugs have been developed for clinical use. The most important class of drugs for the ...

    Authors: Virgilio Gallai† and Paola Sarchielli

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):127

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  8. Sleep disorders and headache are frequently comorbid. Anatomical, biochemical and physiologic common features and pathways could explain the bidirectional influence between sleep disorders and headache. One of...

    Authors: Francomichele Puca†, Maria Pia Prudenzano, Mariantonietta Savarese and Sergio Genco

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):126

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  9. Antidepressants are often used in the prophylaxis of chronic headaches, but their effectiveness is uncertain. A recent meta-analysis showed that antidepressants are effective in the treatment of chronic headac...

    Authors: Lorenzo Pinessi

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):125

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  10. The hypothesis that cortical hyperexcitability may play an important role in the physiopathology of migraine has lead to the therapeutic use of antiepileptic drugs in headache prophylaxis. Cortical hyperexcita...

    Authors: Girolamo Di Trapani, Daniele Mei, Catello Vollono, Alessandro Capuano and Diana Ferraro

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):124

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  11. Triptans are the treatment of choice for migraine sufferers with disabling attacks. However, the proportion of patients reporting side effects after any acute treatment may vary in regard to the method of asse...

    Authors: Michele Feleppa, Fred D. Sheftell, Luciana Ciannella, Amedeo D’Alessio, Giancarlo Apice, Nino N. Capobianco, Donato M. T. Saracino, Walter Di Iorio and Marcelo E. Bigal

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):123

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  12. Despite the pharmacokinetic differences among triptans and the variety of ways of administration, the clinical differences in everyday use of these drugs do not allow a largely accepted decisional tree. There ...

    Authors: Luigi A. Pini and Daria Brovia

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):122

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  13. The importance of the neuropsychological aspect in patients affected by tension headache is highlighted by different data in the literature as well as the results of a multicentric Italian study on comorbidity...

    Authors: Luciana Ciannella, Nino N. Capobianco, Amedeo D’Alessio and Michele Feleppa

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):121

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  14. Pharmacotherapeutic treatments for migraine have been documented for more than a century. Drugs that are effective in aborting an ongoing migraine attack exhibit a diversity of molecular mechanisms of action, ...

    Authors: Graeme Martin

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):120

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  15. Hemicrania continua was described in 1984 by Sjastaad and Spierings as a unilateral, almost always side-locked headache that is continuous and fluctuating in intensity. There are added pain exacerbation period...

    Authors: Alan M. Rapoport and Marcello E. Bigal

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):119

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  16. Patients with chronic daily headache (CDH) are difficult to treat. A combination of general measures and specific pharmacological treatments is necessary. When possible, pharmacological management should be pl...

    Authors: Julio Pascual

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):118

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  17. Migraine is a highly prevalent headache disorder that has a substantial impact on the individual and society. Over the past decade, substantial advances in research have increased understanding of the pathophy...

    Authors: Marcelo E. Bigal and Richard B. Lipton

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):117

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  18. Several studies on patients observed in headache centers show an association between headache, including migraine, and arterial hypertension. As both these pathologies have an elevated prevalence in the genera...

    Authors: Marcello Fanciullacci, Massimo Alessandri, Francesco De Cesaris and Umberto Pietrini

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):116

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  19. The association between headache, especially migraine, and some immunomediated diseases, in particular autoimmune diseases, is well known. The evidence in favor of this association comes prevailingly from epid...

    Authors: Paola Sarchielli, Andrea Alberti, Francesca Coppola and Virgilio Gallai†

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):115

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  20. Migraine and cerebrovascular disease are linked in different ways: migraine may be a potential cause of stroke as in migrainous infarction, headache may be a symptom of cerebrovascular disease and also a risk ...

    Authors: Vittorio Di Piero, Novella Bonaffini and Marta Altieri

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):114

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  21. Placebo and placebo effect are important issues related to the drug therapy for clinical and scientific meanings. The rates of placebo may get as many as 50% for analgesic drugs in headache. The high answer to...

    Authors: Federica Galli, Barbara Riccio and Vincenzo Guidetti

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):113

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  22. Since it is extremely important to fully evaluate the psychological characteristics of young headache sufferers and their family circle, we have implemented a diagnostic therapeutic protocol arranged in a numb...

    Authors: Davide Moscato

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):112

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  23. Research in the field of headache treatment has experienced a marked impetus in the last few years. In the era of the triptans, the treatment modality of this disease has been revolutionised, and though most o...

    Authors: Giovanni Mazzotta, Francesca Floridi, Andrea Alberti and Paola Sarchielli

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):111

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  24. Although migraine is a common complaint in childhood and adolescence, there is a lack of controlled clinical studies regarding treatment. In the young patient, the pharmacological approach should be preceded b...

    Authors: Beatrice Gallai, Giovanni Mazzotta and Paola Sarchielli

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):110

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  25. Children frequently suffer from migraine or tension-type headaches, and the headache pain not only interferes with a patient’s life but can affect his entire family. Headache management includes not only pharm...

    Authors: Francesca Tagliente, Francesca M. Ruju and Antonio Pascotto

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):109

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  26. We reviewed P300 and contingent negative variation (CNV) studies performed in migraine in order to identify their relevance in migraine and the role of neurophysiology in migraine. Publications available to us...

    Authors: Michele Feleppa, Walter Di Iorio and Donato M. T. Saracino

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):108

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  27. Several studies have investigated brain bioelectrical activity with the aid of electroencephalographic brain mapping in migraine patients examined in the interictal period or during a spontaneous attack. The p...

    Authors: Andrea Alberti, Giovanni Mazzotta, Francesca Galletti and Paola Sarchielli

    Citation: The Journal of Headache and Pain 2004 5(Suppl 2):107

    Content type: OriginalPaper

    Published on:

    This article is part of a Supplement: Volume 5 Supplement 2

  28. Headaches can be considered as a paradigm for the so-called “invisible” diseases; difficulties that headache patients encounter and complain from often relate more to the lack of understanding and communicatio...

    Authors: Stefania Radaelli, Matilde Leonardi* and Adriano Pessina

    Citation: The Journal of Headache and Pain 2004 5:104

    Content type: PUBLIC HEALTH SECTION

    Published on:

  29. The objective was to provide objective imaging evidence of functional changes in brainstem structures involved in chronic daily headache (CDH). Over time, episodic migraine (EM) patients may develop CDH known ...

    Authors: Sheena K. Aurora, Vijaya Nagesh and K. Michael A. Welch

    Citation: The Journal of Headache and Pain 2004 5:103

    Content type: BRIEF REPORT

    Published on:

  30. We present a case of cold-induced visual symptoms in a 74-year-old woman with a history of migraine headaches. Migraine without aura was the starting symptom. It coexisted later with a typical pain of ice crea...

    Authors: Luis-C. Álvaro, Fernando Sádaba and Carlos Cortina

    Citation: The Journal of Headache and Pain 2004 5:102

    Content type: BRIEF REPORT

    Published on:

  31. We wanted to document Turkish migraine sufferers’ unconventional therapy methods learnt from their social environment and discuss the historical background and possible action mechanisms of these methods. Unco...

    Authors: H. Macit Selekler and Sezer Komsuoğlu

    Citation: The Journal of Headache and Pain 2004 5:101

    Content type: ORIGINAL

    Published on:

  32. The objective was to measure the cost of botulinum toxin type A (BTX-A) treatment of chronic tension-type headache. A prospective pharmaceutical costing analysis was completed in the Day Hospital of the Region...

    Authors: Fabio Palazzo, Francesco G. Mennini, Laura Fioravanti, Laura Piasini, Gabriella Coloprisco and Paolo Martelletti

    Citation: The Journal of Headache and Pain 2004 5:100

    Content type: ORIGINAL

    Published on:

  33. The objective was to measure the impact of botulinum toxin type A (BTX-A) treatment on symptoms and medication utilisation patterns in patients with chronic tension-type headache. A retrospective chart analysi...

    Authors: Francesco S. Mennini, Laura Fioravanti, Laura Piasini, Fabio Palazzo, Gabriella Coloprisco and Paolo Martelletti

    Citation: The Journal of Headache and Pain 2004 5:99

    Content type: ORIGINAL

    Published on:

  34. The objective was to examine the main genetic and environmental architecture of migraine in the Screening Across Lifetime of Twin (SALT) Study as a function of definition. We performed a quantitative genetic s...

    Authors: Dan A. Svensson, Elisabet Waldenlind, Karl Ekbom and Nancy L. Pedersen

    Citation: The Journal of Headache and Pain 2004 5:96

    Content type: ENRICO GREPPI AWARD

    Published on:

  35. The distinction between suffering and pain express the two faces of a disease that influence a patient quality of life. Suffering is a composite phenomenon. It implies moral elements, such as the question that...

    Authors: Matilde Leonardi, Elena Colombetti, Alessio Musio, Stefania Radaelli and Adriano Pessina

    Citation: The Journal of Headache and Pain 2004 5:88

    Content type: PUBLIC HEALTH SECTION

    Published on:

  36. After complaining of neck pain for 3 weeks, a 36-year-old man suddenly become quadriplegic during a massage session in a traditional Turkish bath. He was immediately transferred to hospital, where the initial ...

    Authors: Ahmet N. Kök, Omer S. Yildirim, Mehmet Kizilkaya, Ali F. Isik, Nasuhi E. Aydin and Talat Yurtman

    Citation: The Journal of Headache and Pain 2004 5:83

    Content type: BRIEF REPORT

    Published on:

  37. A pair of identical twins with cluster headache is described. Monozygosity was confirmed by the identification of 14 DNA markers. In spite of harboring the same genes, the clinical picture presented by the twi...

    Authors: Pedro A. Kowacs, Elcio J. Piovesan, Lineu C. Werneck, Hudson Fameli, Marcos C. Lange and Salmo Raskin

    Citation: The Journal of Headache and Pain 2004 5:82

    Content type: BRIEF REPORT

    Published on:

  38. We applied the second edition of the International Classification of Headache Disorders (ICHD-II) in 417 children (age range, 2–12 years) with chronic headaches attending a pediatric headache clinic. The initi...

    Authors: Marco A. Arruda, Carlos A. Bordini, Marcelo C. Ciciarelli and José G. Speciali

    Citation: The Journal of Headache and Pain 2004 5:81

    Content type: ORIGINAL

    Published on:

  39. This randomized, multicenter, open-label, five-way crossover study was conducted to assess patients’ preference for tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 ...

    Authors: Carl Dahlöf, Martin Jones, Kim Davis, Jane Loftus and Reijo Salonen

    Citation: The Journal of Headache and Pain 2004 5:79

    Content type: ORIGINAL

    Published on:

  40. Cluster headache (CH) is one of the most painful primitive headaches that exists. Since 1991, the subcutaneous administration of sumatriptan (SCS) in the treatment of acute attacks has proved to be rapid and e...

    Authors: Virginie Dousset, Virginie Chrysostome, Bruno Ruiz, S. Irachabal, Magalie Lafittau, Françoise Radat, Bruno Brochet and Patrick Henry

    Citation: The Journal of Headache and Pain 2004 5:78

    Content type: ORIGINAL

    Published on:

  41. We describe a case of tramadol-related respiratory depression in a 69-year-old man, admitted to our hospital because of severe anemia and melena in the context of chronic renal failure and dialysis treatment. ...

    Authors: Consalvo Mattia, Sandro Mazzaferro, Flaminia Coluzzi and Marta Luzi

    Citation: The Journal of Headache and Pain 2004 5:76

    Content type: BRIEF REPORT

    Published on: